Craig Sager’s Leukemia Battle

Craig Sager has been a fixture on NBA sidelines for more than 17 years. Nicknamed “America’s Sideline Reporter” and “Sagervision,” he has always been known for his utterly outlandish and often highly-questionable wardrobe choices:

BGi5Wx4CcAAQorp

His zany suits have become a fun part of his personal brand and an effective way to keep sideline reporting, well, “colorful.”  Unless you ask Kevin Garnett, who (not-so-subtly) suggested that Sager burn his entire outfit, “even the socks” in this 2009 interview:

When Sager was first diagnosed with leukemia in 2014, attention shifted from his fashion statements to his health updates.  Doctors classified Sager as N.E.D. (No Evidence of Disease) in March 2015, and he immediately returned back to the sidelines. Even the usually-grumpy Spurs’ coach, Gregg Popovich was happy to see him.  Unfortunately, after two stem cell transplants, Sager’s cancer has returned for the third time.

Sager told HBO correspondent Bernard Goldberg, that he is “still kicking, still fighting. I haven’t won the battle. It’s not over yet. But I haven’t lost it, either. There have been some victories and some setbacks, but I still have to fight it. I still have a lot of work to do.”

Sager has been given 3-6 months to live, and plans to continue working during that time while fighting Leukemia. He has the hopes and prayers of some of the NBA’s best (see below) and the entire Spero community behind him as he continues his work to get healthy. His goal is to live at least 5 more years and to “make medical history.” Good luck Craig, everyone is rooting for you!

Screen Shot 2016-03-23 at 1.44.36 PM Screen Shot 2016-03-23 at 1.44.12 PM Screen Shot 2016-03-23 at 1.43.56 PMScreen Shot 2016-03-23 at 1.46.19 PM

What are your thoughts on Craig Sager’s Leukemia recurrence? Want to wish him well or connect with others who are fighting cancer? Download the free Spero for Cancer App and keep the conversation going.

BlogPostBottom2

Add a Comment

Your email address will not be published.